|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL.: (2006.01) |
A61K 9/28 A61K 9/30 A61K 31/55 A61K 31/551 A61K 47/30 A61P 25/00 |
| (11) | Number of the document | 4350 |
| (13) | Kind of document | B |
| (21) | Application number | 97-149 |
| (22) | Date of filing the application | 1997-09-16 |
| (41) | Date of publication of the application | 1998-01-26 |
| (45) | Date of publication of patent | 1998-05-25 |
| (86) | Number | PCT/US96/03918 |
| Date | 1996-03-22 |
| (87) | Number | WO 96/29995 |
| Date | 1996-10-03 |
| (30) | Number | Date | Country code |
| 410465 | 1995-03-24 | US |
| (71) |
ELI LILLY AND COMPANY,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (72) |
George Randall COCHRAN, US
Tommy Clifford MORRIS, US |
| (73) |
ELI LILLY AND COMPANY,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | ORAL 2-METHYL-THIENO-BENZODIAZEPINE FORMULATION |
| Payment date | Validity (years) | Amount | |
| 2015-02-19 | 20 | 347.00 EUR |
| Patent expired | ||
| Invalidation date | 2016-03-22 |